Publication 11/20/1999

Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.

Chirmule N, Moffett J, Dhagat P, Tazelaar J, Wilson JM

Human Gene Therapy

Publication 9/01/1999

Immune responses to adenovirus and adeno-associated virus in humans.

Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J

Gene Therapy

Publication 8/17/1999

Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG

Proceedings Of The National Academy Of Sciences Of The United States Of America

Publication 7/01/1999

Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.

Chirmule N, Truneh A, Haecker SE, Tazelaar J, Gao Gp, Raper SE, Hughes JV, Wilson JM

Journal Of Immunology

Publication 5/01/1999

Gene therapy vectors based on adeno-associated virus type 1.

Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM

Journal Of Virology

Publication 1/20/1999

Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.

Chirmule N, Moscioni AD, Qian Y, Qian R, Chen Y, Wilson JM

Human Gene Therapy